Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
In the media 24 Apr 2026 Dengue treatments in 2-3 years, but cases set to rise with climate change Times of India
In the media 23 Apr 2026 India eyes dengue treatment rollout within five years as vaccine pipeline advances The New Indian Express
In the media 26 Mar 2026 Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030” El Mundo
Stories Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases
Scientific articles 14 Apr 2026 Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis Clinical and Translational Science
In the media 11 Apr 2026 Face à la dengue, la recherche s’active alors que le réchauffement laisse craindre une saison 2026 record Le Monde
Scientific articles 27 Mar 2026 Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review BMJ Public Health
Scientific articles 14 Jan 2026 (Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance The Lancet Microbe
Scientific articles 24 Mar 2026 The burden of eumycetoma in Africa: a neglected fungal disease The Lancet Regional Health – Africa
Statements 23 Mar 2026 DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement
Press releases 10 Sep 2015 Drugs for Neglected Diseases initiative and Eisai Co., Ltd. to test drug candidate for Eumycetoma
Press releases 8 Sep 2015 Pivotal clinical trial to begin for first oral drug candidate specifically developed for sleeping sickness
Press releases 7 Sep 2015 Drugs for Neglected Diseases initiative unveils new plan for neglected patients
Press releases 3 Jun 2015 Child-friendly formulation of WHO-recommended treatment now approved by the US FDA for children living with HIV
Press releases 28 May 2015 DNDi and four pharmaceutical companies announce ‘Drug Discovery Booster’ experiment to accelerate and expand discovery of new drugs for two highly neglected diseases – leishmaniasis and Chagas disease
Press releases 11 May 2015 MSF and DNDi Join call for a biomedical research and development fund and mechanism to meet pressing global health needs
Press releases 23 Apr 2015 Ministry of Health and partners disclose recommendations to overcome barriers to access to diagnosis and treatment for Chagas Disease in Colombia
Press releases 16 Dec 2014 DNDi receives US$ 10 million from USAID to develop new drugs for neglected filaria patients
Press releases 9 Dec 2014 Bayer and DNDi sign first agreement to develop an innovative oral treatment for human river blindness
Press releases 1 Dec 2014 World AIDS Day 2014: DNDi welcomes new Medicines Patent Pool licensing agreement and joins PEPFAR, Global Fund, PHTI commitment to reduce HIV treatment gap for HIV-positive children
Press releases 25 Nov 2014 Patient access to miltefosine in developing countries not secure despite award of US FDA PRV sold for USD 125 million
Press releases 25 Nov 2014 Strategic collaboration for developing urgent innovative therapies for neglected diseases in Latin America
Press releases 4 Nov 2014 Artesunate-Mefloquine Fixed-Dose Combination (ASMQ FDC) Proves Safe and Efficacious to Treat Children in Africa with Malaria
Press releases 2 Nov 2014 DNDi Receives USD 60 Million to Fill Research and Development Gaps for Neglected Patients
Press releases 15 Oct 2014 Study Results Support WHO Recommendations for Safe and Effective Kala-azar Treatments in Bangladesh
